Therapeutic Lifestyle Changes Improve HDL Function by Inhibiting Myeloperoxidase-Mediated Oxidation in Patients With Metabolic Syndrome

OBJECTIVE: Phagocyte-derived myeloperoxidase (MPO) and proinflammatory HDL are associated with metabolic syndrome (MetS) and increased cardiovascular disease risk. Therapeutic lifestyle changes (TLCs), such as a Mediterranean diet and exercise, decrease this risk. However, the link among TLCs, HDL,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Care
Autors principals: Mathew, Anna V., Li, Lei, Byun, Jaeman, Guo, Yanhong, Michailidis, George, Jaiswal, Mamta, Chen, Y. Eugene, Pop-Busui, Rodica, Pennathur, Subramaniam
Format: Artigo
Idioma:Inglês
Publicat: American Diabetes Association 2018
Matèries:
Cardiovascular and Metabolic Risk
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6196832/
https://ncbi.nlm.nih.gov/pubmed/30201848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc18-0049
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars